Sangamo Stock Jumps Before Nasdaq Exit: Why SGMO Investors Are Watching May 5
Sangamo Therapeutics shares jumped about 33% Monday as the company prepared to move from Nasdaq to the OTCQB Venture Market following a delisting notice over its sub-$1 share price. Nasdaq is set to suspend trading in SGMO on May 5. Sangamo said it will appeal but expects trading to shift regardless. The company is seeking new funding and continues talks on partnerships and its Fabry disease gene therapy.